RE: Manufacturing / Scalability - US Criteria3 Nov 2021 10:32
Fruitsnveg
Thank you for your very clear, and concise post. Scaling up will not be a problem, we just have to be patient and await the outcomes of the two phase 3 trials.
Covid is, unfortunately, going to be around for many years to come, and many therapeutics will be required to treat the millions of people who will get infected, SNG, will, (providing of course that our phase 3 trials are, as most of us believe, a success) either, via a partnership or alone, develop into a bigger and more profitable company, or, be taken over by one of the big players. Either way phase 3 success will provide a substantial increase in the SP, and more importantly, will save many lives.
Good luck to all fellow investors.